0001209191-17-045272.txt : 20170714
0001209191-17-045272.hdr.sgml : 20170714
20170714200639
ACCESSION NUMBER: 0001209191-17-045272
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170714
FILED AS OF DATE: 20170714
DATE AS OF CHANGE: 20170714
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO THERAPEUTICS, INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
FORMER COMPANY:
FORMER CONFORMED NAME: SANGAMO BIOSCIENCES INC
DATE OF NAME CHANGE: 20000208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Herberts Curt A. III
CENTRAL INDEX KEY: 0001691262
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 17966396
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD.
STREET 2: POINT RICHMOND TECH CENTER
CITY: RICHMOND
STATE: CA
ZIP: 94804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-14
0
0001001233
SANGAMO THERAPEUTICS, INC
SGMO
0001691262
Herberts Curt A. III
C/O SANGAMO THERAPEUTICS, INC.
POINT RICHMOND TECH CTR, 501 CANAL BLVD.
RICHMOND
CA
94804
0
1
0
0
Sr.VP & Chief Business Officer
Common Stock
2017-07-14
4
M
0
172
3.99
A
35517
D
Common Stock
2017-07-14
4
S
0
172
10.00
D
35345
D
Common Stock
2017-07-14
4
S
0
14828
10.00
D
20517
D
Stock Option (Right to Buy)
3.99
2017-07-14
4
M
0
172
0.00
D
2020-10-17
Common Stock
172
3474
D
All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017.
The shares underlying the stock option are fully vested and exercisable.
/s/ Florence Tam, Attorney-in-Fact
2017-07-14